tiprankstipranks
Quince Therapeutics (QNCX)
NASDAQ:QNCX
US Market

Quince Therapeutics (QNCX) Stock Investors

501 Followers
Based on 743,457 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold QNCX
On average, investors allocate 0.00% of their portfolios to QNCX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 743,457 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding QNCX

1.2%
Last 7
Days
0.5%
Last 30
Days
Percentages indicate the change in the number of portfolios holding QNCX, out of 743,457 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

QNCX Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
1.61%
$2.00
Based on the activity of 14,068 investors who made their portfolios public
The table shows changes in QNCX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

QNCX Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
5.75%
-0.58%
-1.48%
33.50B
Consumer Cyclical
ChargePoint Holdings
4.01%
-0.57%
-2.40%
642.21M
Consumer Cyclical
Block
4.15%
-0.53%
-1.34%
39.79B
Technology
Bristol-Myers Squibb
3.22%
-0.24%
+0.96%
84.19B
Healthcare
Marathon Digital Holdings
5.55%
-0.51%
-1.50%
5.42B
Financial
Baidu
5.02%
+0.35%
+10.90%
31.69B
Communication Services
Applied Materials
4.72%
+0.45%
+4.08%
195.39B
Technology
Blink Charging Co
5.19%
-1.32%
-4.59%
276.90M
Industrials
Merck & Company
3.93%
-0.12%
+2.68%
313.56B
Healthcare
AMC Entertainment
5.64%
-0.78%
-1.05%
1.47B
Communication Services
Based on the activity of 743,457 active portfolios
Open your Smart Portfolio

QNCX Investor Analysis

QNCX investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
13.8%
of QNCX holders
are under 35
Average Segment Performance
Average P/E Ratio21.46
Beta7.39
Dividend Yield6.06%
QNCX investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
59.6%
of QNCX holders
are between 35–55
Average Segment Performance
Average P/E Ratio20.66
Beta13.51
Dividend Yield6.08%
QNCX investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
26.6%
of QNCX holders
are over 55
Average Segment Performance
Average P/E Ratio20.71
Beta4.77
Dividend Yield7.20%
Overview of age group and performance of QNCX stock investors
See who invests in QNCX according to age group and performance.

FAQ

How many retail Investors hold QNCX?
<0.1% of TipRanks' retail investors hold QNCX in their portfolios.
    What is QNCX Investor Sentiment?
    QNCX’s Investor Sentiment is Negative.
      What percentage of retail investors changed their holding of QNCX in the last 7 days?
      ▼ 1.2% of TipRanks' retail investors changed their holding of QNCX in the last 7 days.
        What percentage of retail investors changed their holding of QNCX in the last 30 days?
        ▲ 0.5% of TipRanks' retail investors changed their holding of QNCX in the last 30 days.
          What is the average age of retail investors who hold QNCX?
          The average age of QNCX Holders is between 35–55.
            What other stocks have QNCX investors also bought?
            QNCX Investors also bought DKNG, CHPT, SQ, BMY, MARA, BIDU, AMAT, BLNK, MRK, AMC.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              AZNAstraZeneca
              BCRXBioCryst
              BSXBoston Scientific
              DVADaVita
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis